A nurse is instructing a client who has a new diagnosis of Raynaud's disease about preventing the onset of manifestations. Which of the following client statements should indicate to the nurse the need for additional teaching?

A. BP (Blood Pressure): While monitoring blood pressure is important in assessing fluid status, a decrease in blood pressure may indicate inadequate fluid resuscitation rather than adequate replacement. Hypotension may suggest ongoing hypovolemia and the need for further fluid administration.
B. Weight: Weight may provide information about fluid balance over time, but it is not an immediate indicator of adequate fluid replacement during resuscitation. Changes in weight may lag behind changes in fluid status and may not reflect real-time fluid needs.
C. Heart rate: During fluid resuscitation for severe burn injuries, one of the primary goals is to restore intravascular volume and cardiac output. As fluid replacement improves, the heart rate typically decreases, reflecting improved perfusion and reduced sympathetic response.
D. Urine output: Urine output is another critical parameter to monitor during fluid resuscitation, but a decrease in urine output could indicate inadequate fluid replacement rather than adequate replacement.

A. Administer the medication into the deltoid muscle: Olanzapine is typically administered deep into the muscle to ensure proper absorption. However, the deltoid muscle may not be the preferred site for intramuscular injections of medications like olanzapine due to the risk of hitting the underlying radial nerve. The ventrogluteal or vastus lateralis muscles are often preferred sites for IM injections to reduce the risk of nerve damage.
B. Monitor the client for at least 3 hr after the injection: After administering olanzapine IM, the nurse should monitor the client closely for at least 3 hours to assess for any adverse reactions or side effects, such as sedation, hypotension, or extrapyramidal symptoms. This allows for early detection and prompt intervention if needed.
C. Withhold the medication if the client reports hallucinations: Olanzapine is an antipsychotic medication commonly used to treat schizophrenia and other psychotic disorders. Hallucinations are a symptom of schizophrenia, and olanzapine is often prescribed to help manage such symptoms. Withholding the medication solely based on the client reporting hallucinations would not be appropriate without further assessment and consideration of the overall treatment plan.
D. Instruct the client to expect difficulty sleeping: While olanzapine can cause sedation and may affect sleep patterns in some individuals, it is not a universal side effect for everyone. Providing anticipatory guidance about potential side effects is essential, but instructing the client to expect difficulty sleeping without individual assessment may lead to unnecessary anxiety or concerns.